zoledronic acid has been researched along with Otosclerosis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hacking, SA; Jung, DH; Kang, WS; Kashemirov, B; McKenna, CE; McKenna, MJ; Nguyen, K; Quesnel, AM; Sewell, WF; Sun, S | 1 |
Jung, DH; Kang, WS; McKenna, CE; McKenna, MJ; Nguyen, K; Sewell, WF | 2 |
Halpin, C; McKenna, MJ; Merchant, SN; Quesnel, AM; Seton, M | 1 |
4 other study(ies) available for zoledronic acid and Otosclerosis
Article | Year |
---|---|
Non-Ototoxic Local Delivery of Bisphosphonate to the Mammalian Cochlea.
Topics: Animals; Diphosphonates; Ear, Inner; Guinea Pigs; Imidazoles; Otosclerosis; Zoledronic Acid | 2015 |
Intracochlear Drug Delivery Through the Oval Window in Fresh Cadaveric Human Temporal Bones.
Topics: Animals; Bone Density Conservation Agents; Cadaver; Diphosphonates; Ear, Inner; Humans; Imidazoles; Microscopy, Confocal; Otosclerosis; Oval Window, Ear; Temporal Bone; Zoledronic Acid | 2016 |
Measurement of Ototoxicity Following Intracochlear Bisphosphonate Delivery.
Topics: Animals; Cochlea; Diphosphonates; Guinea Pigs; Imidazoles; Otoacoustic Emissions, Spontaneous; Otosclerosis; Zoledronic Acid | 2016 |
Third-generation bisphosphonates for treatment of sensorineural hearing loss in otosclerosis.
Topics: Adult; Aged; Audiometry, Pure-Tone; Auditory Threshold; Bone Conduction; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Hearing Loss, Sensorineural; Humans; Imidazoles; Male; Middle Aged; Otosclerosis; Retrospective Studies; Risedronic Acid; Speech Perception; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid | 2012 |